Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
SKAN Group AG ( (CH:SKAN) ) has issued an announcement.
SKAN Group AG has announced the acquisition of a 76% stake in Metronik d.o.o., a Slovenian company specializing in digital and automated systems for the life sciences sector. This acquisition is expected to enhance SKAN’s digital service portfolio, strengthen its Services & Consumables segment, and positively impact earnings per share in 2025. Metronik’s expertise in software solutions for production management and digital transformation aligns with SKAN’s strategic objectives to accelerate digital transformation and improve operational efficiency. The acquisition is anticipated to close in the third quarter of 2025, subject to regulatory approvals.
The most recent analyst rating on (CH:SKAN) stock is a Buy with a CHF92.00 price target. To see the full list of analyst forecasts on SKAN Group AG stock, see the CH:SKAN Stock Forecast page.
More about SKAN Group AG
SKAN Group AG is a leading company in the field of aseptic and aseptic-toxic manufacturing processes for the (bio-)pharmaceutical industry. It specializes in high-quality isolator systems that ensure strict sterility standards for drug filling. The company also provides process support, services, and consumables, making it a key partner for pharmaceutical and biotech industries, CMOs, and research laboratories worldwide. Founded in 1968, SKAN employs around 1,500 people, with a significant presence in the Life Sciences Hub of the Basel region and subsidiaries across several countries.
Average Trading Volume: 17,604
Current Market Cap: CHF1.63B
Learn more about SKAN stock on TipRanks’ Stock Analysis page.